M Kathleen Behrens - Net Worth and Insider Trading
M Kathleen Behrens Net Worth
The estimated net worth of M Kathleen Behrens is at least $22 Million dollars as of 2024-05-15. M Kathleen Behrens is the Director of Sarepta Therapeutics Inc and owns about 140,517 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $19 Million. M Kathleen Behrens is also the Director of IGM Biosciences Inc and owns about 394,881 shares of IGM Biosciences Inc (IGMS) stock worth over $4 Million. Details can be seen in M Kathleen Behrens's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that M Kathleen Behrens has not made any transactions after 2023-06-26 and currently still holds the listed stock(s).
Transaction Summary of M Kathleen Behrens
M Kathleen Behrens Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, M Kathleen Behrens owns 3 companies in total, including MiMedx Group Inc (MDXG) , IGM Biosciences Inc (IGMS) , and Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of M Kathleen Behrens’s form 4 insider trades.
Insider Ownership Summary of M Kathleen Behrens
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDXG | MiMedx Group Inc | 2019-06-19 | director |
| IGMS | IGM Biosciences Inc | 2023-06-26 | director |
| SRPT | Sarepta Therapeutics Inc | 2021-03-10 | director |
M Kathleen Behrens Latest Holdings Summary
M Kathleen Behrens currently owns a total of 2 stocks. Among these stocks, M Kathleen Behrens owns 140,517 shares of Sarepta Therapeutics Inc (SRPT) as of March 10, 2021, with a value of $19 Million and a weighting of 83.69%. M Kathleen Behrens also owns 394,881 shares of IGM Biosciences Inc (IGMS) as of June 26, 2023, with a value of $4 Million and a weighting of 16.31%.
Latest Holdings of M Kathleen Behrens
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2021-03-10 | 140,517 | 132.66 | 18,640,985 |
| IGMS | IGM Biosciences Inc | 2023-06-26 | 394,881 | 9.20 | 3,632,905 |
Holding Weightings of M Kathleen Behrens
M Kathleen Behrens Form 4 Trading Tracker
According to the SEC Form 4 filings, M Kathleen Behrens has made a total of 2 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 5,000 shares on March 10, 2021, which brought M Kathleen Behrens around $428,800.
According to the SEC Form 4 filings, M Kathleen Behrens has made a total of 7 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in IGM Biosciences Inc is the acquisition of 112,500 shares on June 26, 2023, which cost M Kathleen Behrens around $900,000.
Insider Trading History of M Kathleen Behrens
- 1
M Kathleen Behrens Trading Performance
GuruFocus tracks the stock performance after each of M Kathleen Behrens's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Kathleen Behrens is 22.37%. GuruFocus also compares M Kathleen Behrens's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Kathleen Behrens within 3 months outperforms 8 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how M Kathleen Behrens's insider trading performs compared to the benchmark.
Performance of M Kathleen Behrens
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.23 | | | | | |
| Relative Return to S&P 500(%) | 19.85 | | | | | |
M Kathleen Behrens Ownership Network
M Kathleen Behrens Owned Company Details
What does MiMedx Group Inc do?
Who are the key executives at MiMedx Group Inc?
M Kathleen Behrens is the director of MiMedx Group Inc. Other key executives at MiMedx Group Inc include General Counsel Hulse William Frank Iv , Chief Operating Officer Ricci S Whitlow , and Chief Financial Officer Rice Doug .
MiMedx Group Inc (MDXG) Insider Trades Summary
Over the past 18 months, M Kathleen Behrens made no insider transaction in MiMedx Group Inc (MDXG). Other recent insider transactions involving MiMedx Group Inc (MDXG) include a net sale of 95,935 shares made by Robert Benjamin Stein , a net sale of 65,097 shares made by Hulse William Frank Iv , and a net sale of 54,218 shares made by Peter M Carlson .
In summary, during the past 3 months, insiders sold 51,145 shares of MiMedx Group Inc (MDXG) in total and bought 0 shares, with a net sale of 51,145 shares. During the past 18 months, 290,508 shares of MiMedx Group Inc (MDXG) were sold and 105,000 shares were bought by its insiders, resulting in a net sale of 185,508 shares.
MiMedx Group Inc (MDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.
MiMedx Group Inc Insider Transactions
M Kathleen Behrens Mailing Address
Above is the net worth, insider trading, and ownership report for M Kathleen Behrens. You might contact M Kathleen Behrens via mailing address: 6701 Kaiser Drive, Fremont Ca 94555.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
